{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:28:43Z","timestamp":1793957323294,"version":"4.8.0"},"reference-count":114,"publisher":"Oxford University Press (OUP)","issue":"36","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vaccination is increasingly acknowledged as an effective preventive measure not only against specific infections, but also for the prevention of cardiovascular disease in high-risk patients. Specifically, a growing body of evidence suggests that vaccines against influenza, SARS-CoV-2, respiratory syncytial virus, herpes zoster, and other viruses significantly reduce infection and for influenza the incidence of major adverse cardiovascular events in vaccinated individuals.<\/jats:p>\n                  <jats:p>This clinical consensus statement examines the existing literature and accumulated evidence and offers practical clinical advice on vaccination timing and target demographics, specifically addressing complex clinical scenarios with a focus on cardiovascular conditions. It includes guidelines for vaccinating vulnerable populations such as immunosuppressed individuals, patients with congenital heart disease, and pregnant women as well as safety and potential complications of the procedure.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehaf384","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T07:34:57Z","timestamp":1748331297000},"page":"3518-3531","source":"Crossref","is-referenced-by-count":85,"title":["Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-7920","authenticated-orcid":false,"given":"Bettina","family":"Heidecker","sequence":"first","affiliation":[{"name":"Deutsches Herzzentrum der Charit\u00e9 Berlin , Department of Cardiology, Angiology and Intensive Care, Berlin ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin , Berlin ,","place":["Germany"]},{"name":"Berlin Institute of Health (BIH) at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-502X","authenticated-orcid":false,"given":"Peter","family":"Libby","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital , Heart and Vascular Center of Mass General Brigham, Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios S","family":"Vassiliou","sequence":"additional","affiliation":[{"name":"University of East Anglia , Norwich Medical School, Bob Champion Research and Education, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[{"name":"University of Montpellier, INSERM , Department of Cardiology, Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6387-1351","authenticated-orcid":false,"given":"Orly","family":"Vardeny","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Department of Cardiology, Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-7232","authenticated-orcid":false,"given":"Michael A","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital and Imperial College , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-8890","authenticated-orcid":false,"given":"Mamas A","family":"Mamas","sequence":"additional","affiliation":[{"name":"Keele Cardiovascular Research Group , Department of Cardiology, Staffordshire ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1002-3313","authenticated-orcid":false,"given":"Leslie T","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Schoenrath","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin , Berlin ,","place":["Germany"]},{"name":"Deutsches Herzzentrum der Charit\u00e9 Berlin , Department of Cardiothoracic and Vascular Surgery, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"University of Brescia, Cardiology ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5624-2450","authenticated-orcid":false,"given":"Offer","family":"Amir","sequence":"additional","affiliation":[{"name":"Heart Institute, Hadassah Medical Center, Jerusalem ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Department of Cardiology , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[{"name":"Deutsches Herzzentrum der Charit\u00e9 Berlin, Department of Cardiology, Angiology and Intensive Care, Berlin ,","place":["Germany"]},{"name":"Friede Springer Cardiovascular Prevention Center at Charit\u00e9, Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"L\u00fcscher","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield Hospitals GSTT, Cardiovascular Academic Group, King\u2019s College and Imperial College London , Department of Cardiology, London ,","place":["UK"]},{"name":"Center for Molecular Cardiology, University of Zurich , Zurich,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2026080910071208400_ehaf384-B1","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/ejhf.2669","article-title":"Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases","volume":"24","author":"Heidecker","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026080910071208400_ehaf384-B2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026080910071208400_ehaf384-B3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacc.2022.05.033","article-title":"Cardiovascular disease projections in the United States based on the 2020 census estimates","volume":"80","author":"Mohebi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026080910071208400_ehaf384-B5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026080910071208400_ehaf384-B6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"2026080910071208400_ehaf384-B7","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026080910071208400_ehaf384-B8","doi-asserted-by":"publisher","first-page":"106814","DOI":"10.1016\/j.phrs.2023.106814","article-title":"The burden of hypercholesterolemia and ischemic heart disease in an ageing world","volume":"193","author":"Pirillo","year":"2023","journal-title":"Pharmacol Res"},{"key":"2026080910071208400_ehaf384-B9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jacc.2019.07.061","article-title":"From focal lipid storage to systemic inflammation: JACC review topic of the week","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080910071208400_ehaf384-B10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B11","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.jacc.2024.08.048","article-title":"Excess mortality and hospitalizations associated with seasonal influenza in patients with heart failure","volume":"84","author":"Modin","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026080910071208400_ehaf384-B12","doi-asserted-by":"publisher","first-page":"101740","DOI":"10.1016\/j.eclinm.2022.101740","article-title":"Global, regional and national estimates of influenza-attributable ischemic heart disease mortality","volume":"55","author":"Chaves","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026080910071208400_ehaf384-B13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamacardio.2019.0549","article-title":"Association of influenza-like illness activity with hospitalizations for heart failure: the Atherosclerosis Risk in Communities study","volume":"4","author":"Kytomaa","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026080910071208400_ehaf384-B14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"5","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026080910071208400_ehaf384-B15","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","article-title":"Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction","volume":"142","author":"Modin","year":"2020","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchf.2020.11.003","article-title":"Clinical outcomes in patients with heart failure hospitalized with COVID-19","volume":"9","author":"Bhatt","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2026080910071208400_ehaf384-B17","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/ejhf.2052","article-title":"Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the cardio-COVID-Italy multicentre study","volume":"22","author":"Tomasoni","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026080910071208400_ehaf384-B18","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","article-title":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies","volume":"44","author":"Xu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"2026080910071208400_ehaf384-B20","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B22","doi-asserted-by":"publisher","first-page":"e0221628","DOI":"10.1371\/journal.pone.0221628","article-title":"Transient depression of myocardial function after influenza virus infection: a study of echocardiographic tissue imaging","volume":"14","author":"Ito","year":"2019","journal-title":"PLoS One"},{"key":"2026080910071208400_ehaf384-B23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2009.07.028","article-title":"Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice","volume":"208","author":"Haidari","year":"2010","journal-title":"Atherosclerosis"},{"key":"2026080910071208400_ehaf384-B24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1161\/01.CIR.0000048190.68071.2B","article-title":"Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice","volume":"107","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCRESAHA.120.318511","article-title":"Influenza causes MLKL-driven cardiac proteome remodeling during convalescence","volume":"128","author":"Lin","year":"2021","journal-title":"Circ Res"},{"key":"2026080910071208400_ehaf384-B26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080910071208400_ehaf384-B27","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1161\/01.CIR.96.11.4095","article-title":"Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research","volume":"96","author":"Libby","year":"1997","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B28","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s10096-018-3370-z","article-title":"Viral infection and atherosclerosis","volume":"37","author":"Hemmat","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026080910071208400_ehaf384-B29","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1001\/jama.293.21.2641","article-title":"Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"293","author":"Andraws","year":"2005","journal-title":"JAMA"},{"key":"2026080910071208400_ehaf384-B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.exger.2007.11.009","article-title":"T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire","volume":"43","author":"Rossmann","year":"2008","journal-title":"Exp Gerontol"},{"key":"2026080910071208400_ehaf384-B31","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/01.CIR.0000158479.58589.0A","article-title":"Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein","volume":"111","author":"Maier","year":"2005","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2026080910071208400_ehaf384-B33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijid.2019.08.003","article-title":"Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013\/14\u20132016\/17 seasons)","volume":"88","author":"Rosano","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2026080910071208400_ehaf384-B34","doi-asserted-by":"publisher","first-page":"e228873","DOI":"10.1001\/jamanetworkopen.2022.8873","article-title":"Association of influenza vaccination with cardiovascular risk: a meta-analysis","volume":"5","author":"Behrouzi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026080910071208400_ehaf384-B35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"2026080910071208400_ehaf384-B36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza vaccine in heart failure","volume":"139","author":"Modin","year":"2019","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B37","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"144","author":"Fr\u00f6bert","year":"2021","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B38","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B40","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B41","doi-asserted-by":"publisher","first-page":"20235","DOI":"10.1038\/s41598-023-47690-9","article-title":"Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies","volume":"13","author":"Omidi","year":"2023","journal-title":"Sci Rep"},{"key":"2026080910071208400_ehaf384-B42","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.vaccine.2024.01.040","article-title":"The association between influenza vaccination, cardiovascular mortality and hospitalization: a living systematic review and prospective meta-analysis","volume":"42","author":"Liu","year":"2024","journal-title":"Vaccine"},{"key":"2026080910071208400_ehaf384-B43","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/ejhf.2945","article-title":"Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: a meta-analysis","volume":"25","author":"Modin","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026080910071208400_ehaf384-B44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2020.23649","article-title":"INVESTED Committees and Investigators. Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: a randomized clinical trial","volume":"325","author":"Vardeny","year":"2021","journal-title":"JAMA"},{"key":"2026080910071208400_ehaf384-B45","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","article-title":"Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial","volume":"10","author":"Loeb","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026080910071208400_ehaf384-B46","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200206","article-title":"A pragmatic randomized feasibility trial of influenza vaccines","volume":"2","author":"Johansen","year":"2023","journal-title":"NEJM Evid"},{"key":"2026080910071208400_ehaf384-B47","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s11886-022-01748-8","article-title":"Influenza vaccination for cardiovascular prevention: further insights from the IAMI trial and an updated meta-analysis","volume":"24","author":"Maniar","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2026080910071208400_ehaf384-B48","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1016\/j.vaccine.2015.07.006","article-title":"Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"2026080910071208400_ehaf384-B49","doi-asserted-by":"publisher","first-page":"106276","DOI":"10.1016\/j.jinf.2024.106276","article-title":"Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. Standard-dose quadrivalent influenza vaccine: a post hoc analysis of the DANFLU-1 randomized clinical trial","volume":"89","author":"Christensen","year":"2024","journal-title":"J Infect"},{"key":"2026080910071208400_ehaf384-B50"},{"key":"2026080910071208400_ehaf384-B51","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1038\/s41467-023-39595-y","article-title":"Herpes zoster vaccine safety in the aotearoa New Zealand population: a self-controlled case series study","volume":"14","author":"Mbinta","year":"2023","journal-title":"Nat Commun"},{"key":"2026080910071208400_ehaf384-B52","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","article-title":"Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection","volume":"184","author":"Woodruff","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026080910071208400_ehaf384-B53"},{"key":"2026080910071208400_ehaf384-B54","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B55","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/eurheartj\/ehaa461","article-title":"Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"41","author":"Anker","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B56","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1056\/NEJMoa2106599","article-title":"Effectiveness of mRNA COVID-19 vaccine among U.S. health care personnel","volume":"385","author":"Pilishvili","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B57","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jamainternmed.2023.0750","article-title":"Risk factors associated with post\u2212COVID-19 condition: a systematic review and meta-analysis","volume":"183","author":"Tsampasian","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026080910071208400_ehaf384-B58","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/ejhf.2356","article-title":"COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology","volume":"23","author":"Rosano","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026080910071208400_ehaf384-B59","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/eurheartj\/ehae020","article-title":"Human papillomavirus infection and cardiovascular mortality: a cohort study","volume":"45","author":"Cheong","year":"2024","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B60"},{"key":"2026080910071208400_ehaf384-B61","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.amjmed.2022.09.021","article-title":"The effects of human papillomavirus infection and vaccination on cardiovascular diseases, NHANES 2003\u20132016","volume":"136","author":"Liang","year":"2023","journal-title":"Am J Med"},{"key":"2026080910071208400_ehaf384-B62"},{"key":"2026080910071208400_ehaf384-B63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijid.2020.07.038","article-title":"The protective effect of pneumococcal vaccination on cardiovascular disease in adults: a systematic review and meta-analysis","volume":"99","author":"Marra","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2026080910071208400_ehaf384-B64","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B65","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B66","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001309","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B67","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2026080910071208400_ehaf384-B68","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B69","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/CIRCRESAHA.122.321881","article-title":"Vaccination-associated myocarditis and myocardial injury","volume":"132","author":"Altman","year":"2023","journal-title":"Circ Res"},{"key":"2026080910071208400_ehaf384-B70","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.jacadv.2024.100857","article-title":"Sex and age characteristics in acute or chronic myocarditis: a descriptive, multicenter cohort study","volume":"3","author":"Thevathasan","year":"2024","journal-title":"JACC Adv"},{"key":"2026080910071208400_ehaf384-B71","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B72","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"2026080910071208400_ehaf384-B73","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMc2205667","article-title":"IL-1RA Antibodies in myocarditis after SARS-CoV-2 vaccination","volume":"387","author":"Thurner","year":"2022","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B74","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41467-023-36686-8","article-title":"SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity","volume":"14","author":"Jaycox","year":"2023","journal-title":"Nat Commun"},{"key":"2026080910071208400_ehaf384-B75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imr.12617","article-title":"The role of the interleukin-1 family in trained immunity","volume":"281","author":"Moorlag","year":"2018","journal-title":"Immunol Rev"},{"key":"2026080910071208400_ehaf384-B76","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJMra2114478","article-title":"Myocarditis","volume":"387","author":"Basso","year":"2022","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B77","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B78","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B79","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s12265-020-09983-6","article-title":"A prospective pilot study to identify a myocarditis cohort who may safely resume sports activities 3 months after diagnosis","volume":"14","author":"Patriki","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"2026080910071208400_ehaf384-B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7005a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021\u201322 influenza season","volume":"70","author":"Grohskopf","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2026080910071208400_ehaf384-B81","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3760\/cma.j.cn112338-20230908-00139","article-title":"[Technical guidelines for seasonal influenza vaccination in China (2023\u20132024)]","volume":"44","author":"National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG","year":"2023","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2026080910071208400_ehaf384-B82"},{"key":"2026080910071208400_ehaf384-B83","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B84","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/CRD.0000000000000533","article-title":"Role of influenza vaccination in cardiovascular disease: systematic review and meta-analysis","volume":"32","author":"Gupta","year":"2024","journal-title":"Cardiol Rev"},{"key":"2026080910071208400_ehaf384-B86","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/eurheartj\/ehac737","article-title":"Primary prevention of acute cardiovascular events by influenza vaccination: an observational study","volume":"44","author":"Davidson","year":"2023","journal-title":"Eur Heart J"},{"key":"2026080910071208400_ehaf384-B87","doi-asserted-by":"publisher","first-page":"e2347630","DOI":"10.1001\/jamanetworkopen.2023.47630","article-title":"Electronically delivered nudges to increase influenza vaccination uptake in older adults with diabetes: a secondary analysis of the NUDGE-FLU trial","volume":"6","author":"Lassen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026080910071208400_ehaf384-B88","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(23)00349-5","article-title":"Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial","volume":"401","author":"Johansen","year":"2023","journal-title":"Lancet"},{"key":"2026080910071208400_ehaf384-B89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.14745\/ccdr.v50i34a01","article-title":"Summary of the national advisory committee on immunization (NACI) updated guidance on influenza vaccination during pregnancy","volume":"50","author":"Siu","year":"2024","journal-title":"Can Commun Dis Rep"},{"key":"2026080910071208400_ehaf384-B90","doi-asserted-by":"publisher","first-page":"e0298407","DOI":"10.1371\/journal.pone.0298407","article-title":"Facilitators and barriers to vaccination uptake in pregnancy: a qualitative systematic review","volume":"19","author":"Razai","year":"2024","journal-title":"PLoS One"},{"key":"2026080910071208400_ehaf384-B91","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10875-022-01418-y","article-title":"Clinical practice guidelines for the immunological management of chromosome 22q11.2 deletion syndrome and other defects in thymic development","volume":"43","author":"Mustillo","year":"2023","journal-title":"J Clin Immunol"},{"key":"2026080910071208400_ehaf384-B92","doi-asserted-by":"publisher","first-page":"100359","DOI":"10.1016\/j.ijcchd.2022.100359","article-title":"T cell response to influenza vaccination remains intact in adults with congenital heart disease who underwent early thymectomy","volume":"8","author":"Leone","year":"2022","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"2026080910071208400_ehaf384-B93","doi-asserted-by":"publisher","first-page":"e2310687","DOI":"10.1001\/jamanetworkopen.2023.10687","article-title":"Vaccine-preventable infections among solid organ transplant recipients in Switzerland","volume":"6","author":"Walti","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026080910071208400_ehaf384-B94","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1016\/j.vaccine.2018.08.069","article-title":"Pneumococcal vaccination in adult solid organ transplant recipients: a review of current evidence","volume":"36","author":"Dendle","year":"2018","journal-title":"Vaccine"},{"key":"2026080910071208400_ehaf384-B95","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1111\/ajt.17055","article-title":"Effect of influenza vaccination in solid organ transplant recipients: a nationwide population-based cohort study","volume":"22","author":"Harboe","year":"2022","journal-title":"Am J Transplant"},{"key":"2026080910071208400_ehaf384-B96","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"2026080910071208400_ehaf384-B97","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1111\/j.1600-6143.2009.02917.x","article-title":"Guidelines for vaccination of solid organ transplant candidates and recipients","volume":"9","author":"Danzinger-Isakov","year":"2009","journal-title":"Am J Transplant"},{"key":"2026080910071208400_ehaf384-B98","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.healun.2024.05.010","article-title":"International society for heart and lung transplantation guidelines for the evaluation and care of cardiac transplant candidates-2024","volume":"43","author":"Peled","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"2026080910071208400_ehaf384-B99","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/vaccines11101611","article-title":"Vaccination recommendations in solid organ transplant adult candidates and recipients","volume":"11","author":"Vigano","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2026080910071208400_ehaf384-B100","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/ajt.15101","article-title":"Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation","volume":"19","author":"Pittet","year":"2019","journal-title":"Am J Transplant"},{"key":"2026080910071208400_ehaf384-B101","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"key":"2026080910071208400_ehaf384-B102","doi-asserted-by":"publisher","first-page":"1040.e11","DOI":"10.1016\/j.cmi.2015.07.014","article-title":"Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe","volume":"21","author":"Perez-Romero","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2026080910071208400_ehaf384-B103"},{"key":"2026080910071208400_ehaf384-B104","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.healun.2005.09.015","article-title":"Improving clinical practice: should we give influenza vaccinations to heart transplant patients?","volume":"25","author":"White-Williams","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2026080910071208400_ehaf384-B105","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1016\/j.vaccine.2011.07.050","article-title":"Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination","volume":"29","author":"Lagler","year":"2011","journal-title":"Vaccine"},{"key":"2026080910071208400_ehaf384-B106","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.eurox.2019.100015","article-title":"Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?","volume":"4","author":"Vinkenes","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"2026080910071208400_ehaf384-B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged &gt;\/=19 years: recommendations of the advisory committee on immunization practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"2026080910071208400_ehaf384-B108","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.healun.2021.10.017","article-title":"SARS-CoV-2 vaccination in heart transplantation: what we do and do not know","volume":"41","author":"Aslam","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2026080910071208400_ehaf384-B109","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a thirddose of mRNA-1273 vaccine in transplant recipients","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B110","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA Covid-19 vaccinein solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080910071208400_ehaf384-B111","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series","volume":"174","author":"Werbel","year":"2021","journal-title":"AnnIntern Med"},{"key":"2026080910071208400_ehaf384-B112","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.healun.2021.08.010","article-title":"Third dose of the BNT162b2 vaccinein heart transplant recipients: immunogenicity and clinical experience","volume":"41","author":"Peled","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2026080910071208400_ehaf384-B113","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.acvd.2022.01.005","article-title":"Does the influenza A vaccine have a direct atheroprotective effect?","volume":"115","author":"A\u00efdoud","year":"2022","journal-title":"Arch Cardiovasc Dis"},{"key":"2026080910071208400_ehaf384-B114","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/vaccines11091419","article-title":"Pleiotropic effects of influenza vaccination","volume":"11","author":"Hjelholt","year":"2023","journal-title":"Vaccines (Basel)"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/36\/3518\/63615425\/ehaf384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/36\/3518\/63615425\/ehaf384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T14:07:21Z","timestamp":1786284441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/36\/3518\/8177060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":114,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf384","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,21]]},"published":{"date-parts":[[2025,6,30]]}}}